Huiying Qiu

2.1k total citations
172 papers, 1.2k citations indexed

About

Huiying Qiu is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Huiying Qiu has authored 172 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Hematology, 44 papers in Genetics and 35 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Huiying Qiu's work include Acute Myeloid Leukemia Research (96 papers), Hematopoietic Stem Cell Transplantation (69 papers) and Acute Lymphoblastic Leukemia research (35 papers). Huiying Qiu is often cited by papers focused on Acute Myeloid Leukemia Research (96 papers), Hematopoietic Stem Cell Transplantation (69 papers) and Acute Lymphoblastic Leukemia research (35 papers). Huiying Qiu collaborates with scholars based in China, United States and Japan. Huiying Qiu's co-authors include Depei Wu, Xiaowen Tang, Aining Sun, Yue Han, Suning Chen, Zhengming Jin, Depei Wu, Chengcheng Fu, Yang Xu and Miao Miao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Huiying Qiu

161 papers receiving 1.2k citations

Peers

Huiying Qiu
Dong Soon Lee South Korea
Joan Besalduch Spain
Maro Ohanian United States
F. Maloisel France
Kathryn G. Roberts United States
Michael J. Dugan United States
Pamela Bartels United States
Isamu Sugiura Japan
Nataša Čolović Serbia
Е. Н. Паровичникова Russia
Dong Soon Lee South Korea
Huiying Qiu
Citations per year, relative to Huiying Qiu Huiying Qiu (= 1×) peers Dong Soon Lee

Countries citing papers authored by Huiying Qiu

Since Specialization
Citations

This map shows the geographic impact of Huiying Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiying Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiying Qiu more than expected).

Fields of papers citing papers by Huiying Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiying Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiying Qiu. The network helps show where Huiying Qiu may publish in the future.

Co-authorship network of co-authors of Huiying Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiying Qiu. A scholar is included among the top collaborators of Huiying Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiying Qiu. Huiying Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhibo, Jia Yin, Jun Wang, et al.. (2025). Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 25(10). e731–e739.e4.
2.
Li, Jing, Shiyuan Zhou, Qian Zhu, et al.. (2024). The Role of Pre-existing Anti-HLA Antibodies in Severe Aplastic Anemia Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(9). 902.e1–902.e11. 1 indexed citations
3.
Chen, Ying, et al.. (2024). Risk Factors for Subclinical Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 17. 417–426. 4 indexed citations
4.
5.
Xu, G., Zhao Zeng, Zhibo Zhang, et al.. (2024). The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph‐like ALL. Journal of Cellular and Molecular Medicine. 28(3). e18114–e18114. 2 indexed citations
6.
Zhang, Jian, Yang Xu, Zhihong Lin, et al.. (2024). Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes–Real-World Analyses. Blood. 144(Supplement 1). 6732–6732. 1 indexed citations
7.
Zhang, Lintao, et al.. (2024). Fuzzy C-means clustering algorithm applied in computed tomography images of patients with intracranial hemorrhage. Frontiers in Neuroinformatics. 18. 1440304–1440304. 1 indexed citations
8.
Wang, Hong, Qingyuan Wang, Jiaqian Qi, et al.. (2023). Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning. Frontiers in Immunology. 14. 1146619–1146619. 2 indexed citations
9.
Yin, Minyue, Jinyu Kong, Jian Zhang, et al.. (2023). Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients. Molecular Carcinogenesis. 62(10). 1572–1584. 6 indexed citations
10.
Wen, Lijun, et al.. (2021). Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 22(6). 393–404. 3 indexed citations
11.
Liu, Limin, Yanming Zhang, Huifen Zhou, et al.. (2020). Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases. Bone Marrow Transplantation. 55(10). 2017–2025. 12 indexed citations
12.
Wang, Ziwei, Weiping Zhang, Wei Tang, et al.. (2019). The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation. Annals of Hematology. 98(7). 1765–1773. 7 indexed citations
13.
Zeng, Zhao, Jiannong Cen, Jun Zhang, et al.. (2018). The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China. Leukemia & lymphoma. 59(9). 2152–2158. 4 indexed citations
14.
Yang, Xiaofei, Shuo Yang, Aining Sun, et al.. (2018). Impact of cyclosporine‐A concentration in T‐cell replete haploidentical allogeneic stem cell transplantation. Clinical Transplantation. 32(4). e13220–e13220. 5 indexed citations
15.
Cen, Jiannong, et al.. (2017). Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases. Annals of Hematology. 97(3). 417–424. 8 indexed citations
16.
Gao, Su, Zheng Li, Jianhong Fu, et al.. (2015). Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively. Asian Pacific Journal of Cancer Prevention. 16(15). 6627–6632. 9 indexed citations
17.
Yang, Zhen, Hong Tian, Yang Xu, et al.. (2014). [Clinical outcome of FLT3-ITD (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation].. PubMed. 53(2). 94–8. 2 indexed citations
18.
Chen, Jia, Depei Wu, Feng Chen, et al.. (2013). [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].. PubMed. 93(8). 583–7. 1 indexed citations
19.
He, Guangsheng, Xiang Zhang, Depei Wu, et al.. (2009). Outcomes of CAG Regimen for Refractory Biphenotypic Acute Leukemia Patients. Chinese Medical Sciences Journal. 24(3). 178–181. 4 indexed citations
20.
Qiu, Huiying, et al.. (2003). Establishment of Mouse Embryonic Fibroblast Cell Lines That Promote Ex Vivo Expansion of Human Cord Blood CD34 + Hematopoietic Progenitors. Journal of Hematotherapy & Stem Cell Research. 12(1). 39–46. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Soon Lee Breakdown of academic impact, for papers by Joan Besalduch Breakdown of academic impact, for papers by Maro Ohanian Breakdown of academic impact, for papers by F. Maloisel Breakdown of academic impact, for papers by Kathryn G. Roberts Breakdown of academic impact, for papers by Michael J. Dugan Breakdown of academic impact, for papers by Pamela Bartels Breakdown of academic impact, for papers by Isamu Sugiura Breakdown of academic impact, for papers by Nataša Čolović Breakdown of academic impact, for papers by Е. Н. Паровичникова
Rankless by CCL
2026